Details

Autor(en) / Beteiligte

• Bidaut, Auriane
• Flécher, Erwan
• Nesseler, Nicolas
• Bounader, Karl
• Vincentelli, André
• Moussa, Mouhammed
• Delmas, Clément
• Porterie, Jean
• Nubret, Karine
• Pernot, Mathieu
• Kindo, Michel
• Schneider, Clément
• Gaudard, Philippe
• Rouvière, Philippe
• Michel, Magali
• Sénage, Thomas
• Boignard, Aude
• Chavanon, Olivier
• Verdonk, Constance
• Para, Marylou
• Maille, Baptiste
• Gariboldi, Vlad
• Pozzi, Matteo
• Hugon-Vallet, Elisabeth
• Litzler, Pierre-Yves
• Anselme, Frédéric
• Blanchart, Katrien
• Babatasi, Gerard
• Bielefeld, Marie
• Grosjean, Sandrine
• Radu, Costin
• Hamon, David
• Bourguignon, Thierry
• Genet, Thibaud
• Eschalier, Romain
• D'Ostrevy, Nicolas
• Nougue, Hélène
• Martin, Anne Cécile
• Vanhuyse, Fabrice
• Blangy, Hugues
• Leclercq, Christophe
• Martins, Raphael P
• Galand, Vincent

Titel

Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients

Ist Teil von

• Critical care medicine, 2022-05, Vol.50 (5), p.e426-e433

Ort / Verlag

United States

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Temporary circulatory support (TCS) as a bridge-to-left ventricular assist device (BTL) in cardiogenic shock patients has been increasing, but limited data exists on this BTL strategy. We aimed at analyzing the outcome of BTL patients in a population of cardiogenic shock patients compared with those without TCS at the time of the left ventricular assist device (LVAD) surgery and identify predictors of postoperative mortality in this specific population. A multicenter retrospective observational study conducted in 19 centers from 2006 to 2016. Nineteen French centers. A total of 329 cardiogenic shock patients at the time of LVAD implantation were analyzed. Patients were divided in three groups: those under TCS at the time of LVAD implantation (n = 173), those with TCS removal before LVAD surgery (n = 24), and those who did not undergo a bridging strategy (n = 152). Primary endpoint was 30-day mortality. None. Among the BTL group, 68 (39.3%), 18 (10.4%), and 15 (8.7%) patients were under venoarterial extracorporeal membrane oxygenation, Impella, and IABP support alone, and 72 patients (20.6%) were under multiple TCS support. BTL patients presented similar 30 days survival compared with the TCS removal and non-BTL groups. However, BTL group had a significantly longer ICU duration stay, with two-fold duration of mechanical ventilation time, but the three groups experienced similar postoperative complications. Multivariate analysis identified three independent predictors of mortality in the BTL group: combined surgery with LVAD, body mass index (BMI), and heart failure (HF) duration. BTL strategy was not an independent predictor of mortality in cardiogenic shock patients who underwent LVAD. BTL strategy is not associated with a lower survival among cardiogenic shock patients with LVAD implantation. Predictors of mortality are combined surgery with LVAD, higher BMI, and HF duration.